140 related articles for article (PubMed ID: 17581595)
1. Repeated intracorporeal self-injection: effect on peak systolic velocity and cavernosal artery diameter.
Awad H; El-Karaksy A; Mostafa T; Abbas M; Kamel II; Arafa M; Zeidan A
Int J Impot Res; 2007; 19(5):505-8. PubMed ID: 17581595
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of cavernosal peak systolic velocity in the flaccid penis.
Kahvecioğlu N; Kurt A; Ipek A; Yazicioğlu KR; Akbulut Z
Adv Med Sci; 2009; 54(2):233-8. PubMed ID: 19808161
[TBL] [Abstract][Full Text] [Related]
3. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents--initial experience.
Copel L; Katz R; Blachar A; Sosna J; Sheiman RG
Radiology; 2005 Dec; 237(3):986-91. PubMed ID: 16237136
[TBL] [Abstract][Full Text] [Related]
4. Comparison of one-side and bilateral intracavernosal papaverine injection on a Doppler study of the penis.
Ghafoori M; Hoseini K; Shakiba M
Int J Impot Res; 2009; 21(6):382-6. PubMed ID: 19847184
[TBL] [Abstract][Full Text] [Related]
5. Rehabilitation of the cavernous smooth muscle in patients with organic erectile dysfunction.
Salem H; Mostafa T
Andrologia; 2012 Apr; 44(2):125-9. PubMed ID: 21592173
[TBL] [Abstract][Full Text] [Related]
6. The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography.
Speel TG; Bleumer I; Diemont WL; van der Maas MC; Wijkstra H; Meuleman EJ
Int J Impot Res; 2001 Aug; 13(4):189-91. PubMed ID: 11494073
[TBL] [Abstract][Full Text] [Related]
7. Correlation of duplex sonography with arteriography in patients with erectile dysfunction.
Benson CB; Aruny JE; Vickers MA
AJR Am J Roentgenol; 1993 Jan; 160(1):71-3. PubMed ID: 8416651
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE
Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091
[TBL] [Abstract][Full Text] [Related]
9. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
Seyam R; Mohamed K; Akhras AA; Rashwan H
Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
[TBL] [Abstract][Full Text] [Related]
12. Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction.
Souper R; Hartmann J; Alvarez M; Fuentes I; Astroza G; Marconi M
Int J Impot Res; 2017 Jul; 29(4):132-135. PubMed ID: 28381867
[TBL] [Abstract][Full Text] [Related]
13. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
[TBL] [Abstract][Full Text] [Related]
14. Pharmaco-induced erections for penile color-duplex ultrasound: oral PDE5 inhibitors or intracavernosal injection?
Yang Y; Hu JL; Ma Y; Wang HX; Chen Z; Xia JG; Wang YX; Huang YR; Chen B
Int J Impot Res; 2012 Sep; 24(5):191-5. PubMed ID: 22592761
[TBL] [Abstract][Full Text] [Related]
15. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
[TBL] [Abstract][Full Text] [Related]
16. Sexual impotence caused by vascular disease: diagnosis with duplex sonography.
Benson CB; Vickers MA
AJR Am J Roentgenol; 1989 Dec; 153(6):1149-53. PubMed ID: 2683673
[TBL] [Abstract][Full Text] [Related]
17. Feasability of a novel audio-video sexual stimulation system: an adjunct to the use of penile duplex Doppler ultrasonography for the investigation of erectile dysfunction.
Kuo YC; Liu SP; Chen JH; Chang HC; Tsai VF; Hsieh JT
J Sex Med; 2010 Dec; 7(12):3979-83. PubMed ID: 19912490
[TBL] [Abstract][Full Text] [Related]
18. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
19. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
[TBL] [Abstract][Full Text] [Related]
20. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
